News | August 12, 2024
Ami Organics reports Q1FY25 PAT lower 34% at Rs. 14.7 Cr
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
Vijaya Diagnostic Centre has reported total income of Rs. 159.78 crores during the quarter ended June 30, 2024
SMS Pharmaceuticals has reported total income of Rs. 165.81 crores during the quarter ended June 30, 2024
Divis Laboratories has reported total income of Rs. 2,197 crores during the period ended June 30, 2024
Strong topline growth driven by solid performance across key brands.
Report highlights significant improvements in adolescent well-being in India
Reported profit after tax declined 19% year-on-year to Rs 76 crores
Solara Active Pharma Sciences has reported total income of Rs. 364.05 crores during the period ended June 30, 2024
Detailed data from Phase 3 ECHELON-3 study demonstrate investigational ADCETRIS regimen reduced risk of death by 37 percent compared to chemotherapy alone
Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s
Subscribe To Our Newsletter & Stay Updated
